Author:
Mercuriali Francesco,Inghilleri G.
Reference79 articles.
1. Abels RI, Larholt KM, Krantz KD et al (1991) Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia oof cancer. In: Murphy MJ (ed) Blood Cell Growth Factors: Their present and future in Hematology and oncology. alpha Med Press, Dayton, OH, pp 121–141
2. Anastassiades EG, Howarth D, Howarth J, Shanks D, Waters HM, Hyde K, Geary CG, Liu Yin JA, Gokal R (1993) Monitoring of iron requirements in renal patients on erythropoietin. Nephrol Dial Transplant 8: 846–853
3. Asano Y, Okamura S, Shibuya T, Harada M, Niho Y (1988) Growth of clonogeni myeloblastic leukemia cells in the presence of human recombinant erythropoietin in addition to various human recombinant hemopoietic growth factors. Blood 72: 1382–1386
4. Berdel WE, Oberberg D, Reufii B, Thiel E (1991) Studies on the role of recombinant human erythropoietin in growth regulation of human nonhematopoietic tumor cells in vitro. Ann Hematol 63: 5
5. Biesma DH, Marx JJM, Kraaijenhagen RJ et al (1994) Lower homologous blood requirement in autologous blood donors after ctreatment with recombinant human erythropoietin. Lancet 344: 367–372
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. rhEPO in surgical oncology;Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology;2008